SEARCH

SEARCH BY CITATION

References

  • BATHON, J.M., MANNING, D.C., GOLDMAN, D.W., TOWNS, M.C. & PROUD, D. (1992). Regulation of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1. J. Pharmacol. Exp. Ther., 260, 384392.
  • BATHON, J.M. & PROUD, D. (1991). Bradykinin antagonists. Annu. Rev. Pharmacol., 31, 129162.
  • BHOOLA, K.D., FIGUEROA, C.D. & WORTHY, K. (1992). Bioregulation of kinins: kallikreins, kininigens, and kininases. Pharmacol. Rev., 44, 180.
  • BRAIN, S.D. & WILLIAMS, T.J. (1989). Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin. Br. J. Pharmacol., 97, 7782.
  • BUCKLEY, T.L., BRAIN, S.D., RAMPART, M. & WILLIAMS, T.J. (1991). Time-dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP) and mediators of inflammation. Br. J. Pharmacol., 103, 15151519.
  • BURCH, R.M., CONNOR, J.R. & AXELROD, J. (1988). Interleukin-1 amplifies receptor-mediated activation of phospholipase A2 in 3T3 fibroblasts. Proc. Natl. Acad. Sci. U.S.A., 85, 63066309.
  • BURCH, R.M., CONNOR, J.R. & TIFFANY, C.W. (1989a). The kallikrein-kininogen system in chronic inflammation. Agents Action., 27, 258260.
  • BURCH, R.M. & DEHAAS, C. (1990). A bradykinin antagonist inhibits carrageenin edema in rats. Naunyn-Schmied. Arch Pharmacol., 342, 189193.
  • BURCH, R.M., KYLE, D.J. & STORMENN, T.M. (1993). Molecular Biology and Pharmacology of Bradykinin Receptors. ed. Burch R.M., pp. 107. Austin, Texas: R.G. Landes Co..
  • BURCH, R.M. & TIFFANY, C.W. (1989). Tumor necrosis factor causes amplification of arachidonic acid metabolism in response to interleukin-1, bradykinin, and other agonists. J. Cell Physiol., 141, 8589.
  • BURCH, R.M., WHITE, M.F. & CONNOR, J.R. (1989b). Interleukin 1 stimulate prostaglandin synthesis and cyclic AMP accumulation in swiss 3T3 fibroblast: Interaction between two second messenger systems. J. Cell. Physiol., 139, 2933.
  • BURGESS, G.M., MULLANEY, I., mc NEIL, M., COOTE, P.R., MINHAS, A. & WOOD, J.N. (1989). Activation of guanylate cyclase by bradykinin in rat sensory neurons is mediated by calcium influx: Possible role of increase in cyclic GMP. J. Neurochem., 53, 12121218.
  • CORRÊA, C.R. & CALIXTO, J.B. (1993). Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br. J. Pharmacol., 110, 193198.
  • CRUWYS, S.C., KIDD, B.L., MAPP, P.I., WALSH, D.A. & BLAKE, D.R. (1992). The effects of calcitonin gene-related peptide on formation of intra-articular oedema by inflammatory mediators. Br. J. Pharmacol., 107, 116119.
  • DAMAS, J., BOURDON, V., REMACLE-VOLON, G. & ADAM, A. (1990). Kinins and peritoneal exudates induced by carrageenin and zymosan in rats. Br. J. Pharmacol., 101, 418422.
  • DEBLOIS, D., BOUTHILLIER, J. & MARCEAU, F. (1988). Effect of glucocorticoids, monokines and growth factor on the spontaneously developing responses of the rabbit isolated aorta to des-Arg9-Bradykinin. Br. J. Pharmacol., 93, 969977.
  • DEBLOIS, D., BOUTHILLIER, J. & MARCEAU, F. (1991). Pulse exposure to protein synthesis inhibitors enhances tissue response to des-Arg9-bradykinin: possible role of interleukin-1. Br. J. Pharmacol., 103, 314315.
  • DRAY, A., PATEL, I.A., PERKINS, M.N. & RUEFF, A. (1992). Bradykinin-induced activation of nociceptors: receptor studies on neonatal rat spinal cord-tail preparation in vitro Br. J. Pharmacol., 107, 11291134.
  • DRAY, A. & PERKINS, M.N. (1993). Bradykinin and inflammatory pain. Trends Neurosci., 16, 99104.
  • FARMER, S.G. & BURCH, R.M. (1992). Biochemical and molecular pharmacology of kinin receptors. Annu. Rev. Pharmacol. Toxicol., 32, 511532.
  • FARMER, S.G., mc MILLAN, B.A., MEEKER, S.N. & BURCH, R.M. (1991). Induction of vascular smooth muscle bradykinin B1 receptor. Agents Actions, 34, 191193.
  • FERREIRA, S.H., LORENZETTI, B.B. & POOLE, S. (1993). Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol., 110, 12271231.
  • GAGINELLA, T.S. & KACHUR, J.F. (1989). Kinin mediators of intestinal secretion. Am. J. Physiol., 256, G1G15.
  • GARCIA LEME, J., (1978). Bradykinin system. In Handbook of Experimental Pharmacology, Vol. 50, Inflammation, ed. Vane, J.R. & Ferreira, S.H. pp. 464522. Berlin: Springer-Verlag.
  • GEPPETTI, P. (1993). Sensory neuropeptide release by bradykinin; mechanisms and pathophysiological implications. Regul. Pept., 47, 123.
  • HALL, J.M. (1992). Bradykinin receptors pharmacological properties and biological roles. Pharmacol. Ther., 56, 131190.
  • HARGREAVES, K.M., TROULLOS, E.S., DIONNE, R.A., SCHMIDT, R.N., SCHAFER, S.C. & JORIS, J.L. (1988). Bradykinin is increased during acute and chronic inflammation: therapeutic implications. Clin. Pharmac. of Ther., 44, 613621.
  • HEAPY, C.G., SHAW, J.S. & FARMER, S.C. (1993). Differential sensitivity of antinoceptive assays to the bradykinin antagonist Hoe 140. Br. J. Pharmacol., 108, 209213.
  • IMAMURA, K., SHERMAN, M.L. & SPRIGGS, D. (1988). Effect of tumor necrosis factor on GTP binding and GTP-ase activity in HL-6 and L-929 cells. J. Biol. Chem., 263, 1024710253.
  • KYLE, D.J. & BURCH, R.M. (1993). A survey of bradykinin receptors and their antagonists. Curr. Opin. Invest. Drugs, 2, 520.
  • LANG, E., NOVAK, A., REEH, P.W. & HANDWERKER, H.O. (1990). Chemosensitivity to fine afferents from rat skin in vitro J. Neurophysiol., 63, 887901.
  • LEWIS, G.P. (1970). Kinin in inflammation and tissue injury. In Handbook of Experimental Pharmacology, Vol. XXV, ed. Erdos, E.G. pp. 516530. Berlin: Springer-Verlag.
  • mc GEHEE, D.S., GOY, M.F. & OXFORD, G.S. (1992). Involvement of nitric oxide-cyclic GMP pathway in desensitization of bradykinin responses of cultured sensory neurons. Neuron, 9, 315324.
  • MARCEAU, F., LUSSIER, A., REGOLI, D. & GIROUD, J.P. (1983). Pharmacology of kinins; their relevance to tissue injury and inflammation. Gen. Pharmacol., 14, 209229.
  • MARCEAU, F. & REGOLI, D. (1991). Kinin receptors of the B1 type and their antagonists: In Bradykinin Antagonists: Basic and Clinical Research. ed. Burch, R.M. pp. 3349. New York: Marcel Dekker.
  • MARTINS, M.A., PASQUALE, C.P., BOZZA, P.T., SILVA, P.M.R., FARIA, H.C.C.N. & CORDEIRO, R.S.B. (1992). Homologous tachyphylaxis to bradykinin and its interference with allergic pleurisy in actively sensitized rats. Eur. J. Pharmacol., 220, 5561.
  • MUNOZ, C.M. & LEEB-LUNDBERG, L.M.F. (1992). Receptor-mediated internalization of bradykinin. J. Biol. Chem., 267, 303309.
  • PERKINS, M.N. & KELLY, D. (1993). Induction of bradykinin-B1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br. J. Pharmacol., 110, 14411444.
  • PROUD, D. & KAPLAN, A.P. (1988). Kinin formation: mechanisms and role in inflammatory disorders. Annu. Rev. Immunol., 6, 4983.
  • REGOLI, D. & BARABÉ, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 146.
  • ROSCHER, A.A., MANGANIELLO, V.C., JELSEMA, C.L. & MOSS, J. (1984). Autoregulation of bradykinin receptors and bradykinin-induced prostacyclin formation in human fibroblasts. J. Clin. Invest., 74, 552558.
  • ROSCHER, A.A. & MANGANIELLO, V.C. (1984). Glucocorticoids reduce the number of specific bradykinin receptors in cultured human fibroblasts. Clin. Res., 32, 468A.
  • ROSCHER, A.A., KLIER, C. & DENGLER, R. (1990). Regulation of bradykinin action at the receptor level. J. Cardiovasc. Pharmacol., 6, S39S43.
  • STERANKA, L.R. & BURCH, R.M. (1991). Bradykinin antagonists in pain and in inflammation. In Bradykinin Antagonists: Basic Clinical Research. ed. Burch, R.M. pp. 171189. New York: Marcel Dekker.
  • TIFFANY, C.W. & BURCH, R.M. (1989). Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophage. FEBS Lett., 247, 774777.
  • WARREN, J.B., WILSON, A.J., LOI, R.K. & COUGHLAN, M.L. (1993). Opposing roles of cyclic AMP in the vascular control of edema formation. FASEB J., 7, 13941400.
  • WIRTH, K., HOCK, F.J., ALBUS, U., LINZ, W., ALPERMANN, H.G., AGNOSTOPOULOS, H., HENKE, H., BREIPHOL, S., KÖNIG, G., KNOLLE, W. & SCHÖLKENS, B.A. (1991). Hoe 140 a new potent and long-acting bradykinin antagonist: in vitro studies. Br. J. Pharmacol., 102, 774777.
  • WOLSING, D.H. & ROSENBAUUM, J.S. (1993). The mechanism for the rapid desensitization in bradykinin-stimulated inositol monophosphate production in NG 108–15 cells involves interaction of a single receptor with multiple signalling pathways. J. Pharmacol. Exp. Ther., 266, 253261.